{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:32:51Z","timestamp":1791484371132,"version":"4.3.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tic disorders (TDs) are chronic neuropsychiatric disorders that usually begin in childhood. Currently, antipsychotic drugs, such as aripiprazole and risperidone, are frequently used to treat TD. However, adverse reactions limit their further usage. The efficacy of topiramate has been reported in recent studies. This study aimed to investigate the efficacy and tolerability of topiramate in the treatment of children with TDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, we performed a meta-analysis to assess the efficacy and tolerability of topiramate for TDs and identified the randomized controlled trials to evaluate topiramate for children with TDs from PubMed, the China National Knowledge Infrastructure database, Web of Science, and relevant reference lists. Quality assessment followed the Cochrane Handbook for Systematic Reviews of Interventions. A modified Jadad scale was used to assess the quality of included studies. Risk ratio (RR) was calculated as the effect size of efficacy and tolerability of topiramate for TDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 15 studies involving 1070 participants aged 2\u201317 were included in the present meta-analysis, and 693 (64.71%) participants were male cases, with 14 studies evaluating the efficacy of topiramate for the treatment of TD. The results suggested that topiramate was more effective than control drugs (RR: 1.13, 95% confidence interval: [1.06\u20131.20],\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200936%,\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      \u2009=\u200920.31,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.09). For the adverse events, there were 15 trials included in the meta-analysis, and the results showed that topiramate had fewer adverse events than control drugs (RR: 0.54, 95% confidence interval: [0.46\u20130.65],\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200945%,\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      \u2009=\u200925.49,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Compared with haloperidol and tiapride, topiramate appears to be a promising medication with good efficacy and tolerability for children with TDs. In future studies, large-sample, double-blind, placebo-controlled trials are needed to confirm its efficacy and tolerability compared with atypical antipsychotic agents (such as risperidone or aripiprazole).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2019.0161","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T09:19:13Z","timestamp":1584609553000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["Revisiting the Efficacy and Tolerability of Topiramate for Tic Disorders: A Meta-Analysis"],"prefix":"10.1177","volume":"30","author":[{"given":"Liping","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjuan","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingran","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"976","article-title":"Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"Afshar H","year":"2014","unstructured":"Afshar H, , Akuchekian S, , Mahaky B, , Zarean E: Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial. J Res Med Sci, 19:976\u2013981, 2014.","journal-title":"J Res Med Sci"},{"key":"e_1_3_3_3_1","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 4th ed. Washington DC: American Psychiatric Association; 1994."},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th ed. Washington DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05266gre"},{"key":"e_1_3_3_6_1","unstructured":"Cai X: Effect of topiramate on children with multiple tic disorder. J Pract Med. 31:1702\u20131704 2015 (Article in Chinese)."},{"key":"e_1_3_3_7_1","first-page":"20","article-title":"Comparison of clinical efficacy and safety between topiramate and thiophene in the treatment of multiple tic disorder in children","volume":"23","author":"Chen J","year":"2017","unstructured":"Chen J: Comparison of clinical efficacy and safety between topiramate and thiophene in the treatment of multiple tic disorder in children. J Pediatr Pharm, 23:20\u201322, 2017 (Article in Chinese).","journal-title":"J Pediatr Pharm"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.03.013"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12283"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13209"},{"key":"e_1_3_3_11_1","unstructured":"Gan R : Clinical observation on the role of topiramate in the treatment of child Tourette's syndrome. Hei Long Jiang Med 36:458\u2013460 2012 (Article in Chinese)."},{"key":"e_1_3_3_12_1","first-page":"17","article-title":"Combination phentermine-topiramate extended release for the treatment of binge eating disorder: An open-label, prospective study","volume":"15","author":"Guerdjikova AI","year":"2018","unstructured":"Guerdjikova AI, , Williams S, , Blom TJ, , Mori N, , McElroy SL: Combination phentermine-topiramate extended release for the treatment of binge eating disorder: An open-label, prospective study. Innov Clin Neurosci, 15:17\u201321, 2018.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2019.02.003"},{"key":"e_1_3_3_14_1","first-page":"37","article-title":"Clinical analysis of topiramate in the treatment of multiple tic disorder in children","volume":"27","author":"Hu H","year":"2017","unstructured":"Hu H: Clinical analysis of topiramate in the treatment of multiple tic disorder in children. J Shanxi Med Coll Continuing Educ, 27:37\u201339, 2017 (Article in Chinese).","journal-title":"J Shanxi Med Coll Continuing Educ"},{"key":"e_1_3_3_15_1","unstructured":"Huang X : The clinic efficacy of topamax in the treatment of Tourette's syndrome. Med J West China 19:261\u2013262 2007 (Article in Chinese)."},{"key":"e_1_3_3_16_1","unstructured":"Huang Y Wang J Fang P : Clinical study of topiramate in treating with childhood Tourette's syndrome. North SiChuan Med Coll. 22:437\u2013439 2007 (Article in Chinese)."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.185348"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000017"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181c295c1"},{"key":"e_1_3_3_21_1","first-page":"129","article-title":"The efficacy analysis of topiramate in treatment of Tourette's syndrome in children [in Chinese]","volume":"1","author":"Li A","year":"2011","unstructured":"Li A: The efficacy analysis of topiramate in treatment of Tourette's syndrome in children [in Chinese]. China Foreign Med, 1:129, 2011.","journal-title":"China Foreign Med"},{"key":"e_1_3_3_22_1","first-page":"114","article-title":"The efficacy evaluation of topiramate in treating with childhood Tourette's syndrome","volume":"20","author":"Li J","year":"2008","unstructured":"Li J: The efficacy evaluation of topiramate in treating with childhood Tourette's syndrome. Strait Pharmaceut, 20:114\u2013115, 2008 (Article in Chinese).","journal-title":"Strait Pharmaceut"},{"key":"e_1_3_3_23_1","first-page":"4192","article-title":"The efficacy of Topamax in the treatment of Tourette's syndrome","volume":"26","author":"Liang G","year":"2010","unstructured":"Liang G, , Yao G: The efficacy of Topamax in the treatment of Tourette's syndrome. Pract Med, 26:4192\u20134193, 2010 (Article in Chinese).","journal-title":"Pract Med"},{"key":"e_1_3_3_24_1","first-page":"351","article-title":"The comparison study of the therapeutic effect of topiramate and haloperidol in children with Tourette syndrome","volume":"21","author":"Lin Y","year":"2004","unstructured":"Lin Y, , Lin G, , Lin J, , Wu Y, , Qiu Y: The comparison study of the therapeutic effect of topiramate and haloperidol in children with Tourette syndrome. Xinxiang Med Coll, 21:351\u2013353, 2004 (Article in Chinese).","journal-title":"Xinxiang Med Coll"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170320104237"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852912000065"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.02.001"},{"key":"e_1_3_3_28_1","article-title":"Topiramate versus carbamazepine monotherapy for epilepsy","author":"Nevitt SJ","year":"2019","unstructured":"Nevitt SJ, , Sudell M, , Tudur Smith C, , Marson AG: Topiramate versus carbamazepine monotherapy for epilepsy: An individual participant data review. Cochrane Database Syst Rev CD012065, 2019.","journal-title":"An individual participant data review"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S125367"},{"key":"e_1_3_3_30_1","first-page":"116","article-title":"The use of topiramate for weight loss causing acute glaucoma: A case report and literature review","volume":"8","author":"Oliveira B","year":"2019","unstructured":"Oliveira B, , Ferrari P, , Herrerias B, , Hirai F, , Gracitelli C: The use of topiramate for weight loss causing acute glaucoma: A case report and literature review. Med Hypothesis Discov Innov Ophthalmol, 8:116\u2013120, 2019.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.09.025"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007466"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0486-0"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180828095131"},{"key":"e_1_3_3_35_1","article-title":"A controlled study of the clinical effects of duodongning capsule,topiramate and aripiprazole in the treatmen of Tic disorders","author":"Su H","year":"2015","unstructured":"Su H: A controlled study of the clinical effects of duodongning capsule,topiramate and aripiprazole in the treatmen of Tic disorders. MSc Dissertation, 2015 (in Chinese).","journal-title":"MSc Dissertation"},{"key":"e_1_3_3_36_1","first-page":"21","article-title":"Effect of topiramate on children with tic disorder and plasma glutamate and aspartate levels in children","volume":"19","author":"Tao R","year":"2013","unstructured":"Tao R: Effect of topiramate on children with tic disorder and plasma glutamate and aspartate levels in children. J Pediatr Pharm, 19:21\u201323, 2013 (Article in Chinese).","journal-title":"J Pediatr Pharm"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.20118"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.10.007"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-118665"},{"key":"e_1_3_3_40_1","first-page":"52","article-title":"Clinical research of topiramate in treating with childhood Tourette's syndrome","volume":"20","author":"Wang G","year":"2008","unstructured":"Wang G, , Li M, , Chen B: Clinical research of topiramate in treating with childhood Tourette's syndrome. Tianjin Pharm, 20:52\u201353, 2008 (Article in Chinese).","journal-title":"Tianjin Pharm"},{"key":"e_1_3_3_41_1","first-page":"139","article-title":"Therapeutic effect of aripiprazole and topiramate on refractory tic disorder","volume":"36","author":"Wang L","year":"2015","unstructured":"Wang L: Therapeutic effect of aripiprazole and topiramate on refractory tic disorder. J Med Forum, 36:139\u2013140, 2015 (Article in Chinese).","journal-title":"J Med Forum"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.04.013"},{"key":"e_1_3_3_43_1","unstructured":"Wang X: Clinical application of topiramate in children with multiple tic disorder. China Children's Health J. 12:414 422 2004 (Article in Chinese)."},{"key":"e_1_3_3_44_1","first-page":"66","article-title":"Effect of topiramate on children with multiple tic disorder","volume":"23","author":"Yan J","year":"2016","unstructured":"Yan J: Effect of topiramate on children with multiple tic disorder. Contemp Chinese Med, 23:66\u201368, 2016 (Article in Chinese).","journal-title":"Contemp Chinese Med"},{"key":"e_1_3_3_45_1","article-title":"Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis","volume":"98","author":"Yang C","year":"2019","unstructured":"Yang C, , Yi Q, , Zhang L, , Cui H, , Mao J: Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis. Medicine, 98:e15816, 2019.","journal-title":"Medicine"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004354"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.05.002"},{"key":"e_1_3_3_48_1","unstructured":"Yao Y: Comparative analysis of topiramate and sulpiride in the treatment of multiple tic disorder in children. Guide China Med. 11:16\u201317 2013 (Article in Chinese)."},{"key":"e_1_3_3_49_1","unstructured":"Zheng W Zhang N Yang J Li X Ma X Xiang Y:Meta-analysis of topiramate and haloperidol in the treatment of children with tic disorder. Chinese J Child Health Care 23:303\u2013306 2015 (Article in Chinese)."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2018.12.009"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2019.0161","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2019.0161","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2019.0161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:55:47Z","timestamp":1777388147000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2019.0161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1089\/cap.2019.0161"],"URL":"https:\/\/doi.org\/10.1089\/cap.2019.0161","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}